Metabolic Syndrome and obesity

30

obesity

Metabolic Syndrome and obesity

The epidemic of the XXI Century.

Metabolic syndrome is so difficult to comprehend for patients as it is for physicians. The answer is not the application of medicine such as amphetamines and magical slimming products, nor is it in the excessive amount of exercise, hipocaloric diets, anorexia, bulimia, etc. that make the patients metabolic issues even worse.

MS is a profound metabolic alteration that requires medical attention and the knowledge, understanding, research, nutritional guidance and medical guidance, all unique to each patient.

Metabolic Syndrome is becoming every time more common in Mexico, United States, and in central and South America. Researchers aren’t sure if the syndrome is due to a single cause, but all of its risk factors are related to obesity.

 

The most important risk factors for metabolic syndrome are:

  • Added weight around the central and superior parts of the body (centric obesity)
  • Abdominal fat that is impossible to lose with exercise and diets.
  • The body could be described as “apple-shaped”
  • Insulin resistance: the body utilizes insulin in a less efficient manner than usual.
  • Insulin is needed to help control the amounts of sugar in the body. As a result, sugar and fat levels in blood increase.

 

Other risk factors that cause metabolic syndrome are:

  • Old age.
  • Genetic predisposition.
  • Hormonal changes.
  • Lack of exercise.
  • Hormonal failure (menopause or andropause)
  • Hereditary factors that encourage insulin resistance, like close relatives with type 1 or 2 diabetes.
  • Genetic modifications due to physical or psychological stress.
  • Depression
  • Low energy.
  • Alterations in sleep, nutrition and daily exercise.
  • Sedentary lifestyle.
  • Medicine for losing weight.
  • Sleeping medication.
  • Antidepressive medication
  • Deficient nutrition
  • Foods contaminated by conservatives.

People with metabolic syndrome often have other medical problems that may cause or worsen this condition, such as:

  • Excessive blood coagulation.
  • Increase in blood levels, meaning a system-wide inflammation process.
  • Increase in cholesterol, triglycerides, and hormonal unbalance.
  • Increase in glucose and glucolized hemoglobin.

The insulin resistance syndrome, currently known as metabolic syndrome (MS) is mostly known by being the major cause of cardiovascular disease and diabetes, in clinical practice its early detection and management is vital. Insulin resistance (IR) is a metabolic condition during MS and its diagnose may be done by measuring insulin and glucose levels during fastening with a test for glucose tolerance with insulin curve and glucolized hemoglobin. These variables make the patient with these conditions easy to control and maintain in a healthy state.

It is generally agreed that best results in controlling MS and RI are achieved by altering the patient’s lifestyle, including modifications to their diet and physical activity, along with weight loss and fat loss. There are some pharmacological therapies available oriented at increasing insulin sensitivity in patients with high risk of type 2 diabetes and cardiovascular disease.

Therapies for increasing insulin sensitivity are recommended by international consensus, especially in patients with high risk of type 2 diabetes and cardiovascular disease, when all other types of therapies may fail.

 

The Mexican Medical Association for the study of Metabolic Syndrome.

Currently one of the best in the world, if not the best, gathers all national and international physicians that are interested in recent studies and developments in Metabolic Syndrome in Mexico City each year, during the month of August in the XXI Century Medical Center. There, advancements in medical research are discussed in both national and international levels, and knowledge is transmitted from researchers directly to physicians.

The next annual conference for the study of Metabolic Syndrome will take place on  August.

 

 

Comments are closed.